Skip to content

Fact Sheet: Ncyte® Microglia

Get information on Ncardia’s Ncyte® Microglia, human iPSC-derived microglia that can help advance CNS and neurodegenerative therapy research
DOWNLOAD NOW
Microglia Fact Sheet

Discover Ncyte® Microglia

Ncyte hiPSC-derived Microglia—high-purity microglia capable of phagocytosis and cytokine release—replicate the behavior of human microglia, providing researchers with a robust, readily available, and physiologically relevant system for examining microglial interactions, responses to central nervous system injury, and disease mechanisms.

Especially suited for co-culture and neuroinflammation studies, they support the advancement of therapeutic research and development for CNS disorders and a range of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and ALS.

 




ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the fact sheet by filling out the form below: